Humana Inc. reported a significant earnings beat for Q1, with adjusted earnings per share (EPS) of $7.23, surpassing the estimated $6.12. The company also reported adjusted sales of $29.332 billion, exceeding expectations of $28.473 billion, and total revenue of $29.61 billion against an expectation of $28.28 billion. Additionally, Humana confirmed its full-year 2024 adjusted EPS guidance of approximately $16.00, slightly below the estimated $16.36, and raised its 2024 individual Medicare Advantage annual membership growth forecast by 50,000. This performance comes amid a backdrop where competitors UnitedHealth and Elevance Health reported no further spikes in Q1 medical costs related to Medicare Advantage (MA), despite Humana's significant concentration in MA.
Humana’s stock surges on big earnings beat, raised outlook for Medicare Advantage membership growth https://t.co/qVBo8XpRiX
$HUM | Humana Q1 Earnings: - Adj EPS $7.23 (Est. $6.12) 🟢 - Adj Sales $29.332B (Est. $28.473B) 🟢 - Affirms FY24 Adjusted EPS Outlook Of Approximately $16.00 (Est $16.36) - Raises 2024 Individual Medicare Advantage Annual Membership Growth By 50,000 To Now Anticipate Annual… https://t.co/VugqWLIGtY
$HUM | Humana Q1 24 Earnings: -Adj EPS: $7.23 (exp $6.04) -Revenue: $29.61B (exp $28.28B) -Affirms FY Adj Financial Guidance
$HLT | Hilton Worldwide Holdings Q1 Earnings: - Adj EPS $1.53 (Est. $1.42) 🟢 - Sales $2.573B (Est. $2.550B) 🟢 - Expects Q2 Adjusted EPS Of $1.80-$1.86 (Est. $1.88) - Boosts FY24 Adj EPS Outlook From $6.80-$6.94 To $6.89-$7.03 (Est. $7.12) https://t.co/iIqbt2wnZv
$HUM reports ahead of the bell tomorrow. Q1 estimates: $6.12 eps on $28.47 B revenues. The key number MLR: Q4 saw a higher than expected 90.5% Q1 estimate is 88.9% While $UNH and $ELV didn't report any further MA medical cost spike Q1, $HUM is much more concentrated in MA. https://t.co/T65nGMD3Vr